Sfoglia per AUTORE
TORTA M
Collezione AOU San Luigi di Orbassano

  

Items : 15

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.

2011
AOU San Luigi di Orbassano

Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.

2009
AOU San Luigi di Orbassano

Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. in The Journal of urology / J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129. doi: 10.1016/j.juro.2007.05.018. Epub 2007 Jul 16.

2007
AOU San Luigi di Orbassano

Berruti A; Mosca A; Porpiglia F; Bollito E; Tucci M; Vana F; Cracco C; Torta M; Russo L; Cappia S; Saini A; Angeli A; Papotti M; Scarpa RM; Dogliotti L;

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. in Journal of endocrinological investigation / J Endocrinol Invest. 2005;28(11 Suppl International):141-5.

2005
AOU San Luigi di Orbassano

Mosca A; Berruti A; Russo L; Torta M; Dogliotti L;

Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. in The International journal of biological markers / Int J Biol Markers. 2002 Oct-Dec;17(4):244-52. doi: 10.5301/jbm.2008.2194.

2002
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A;

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients. in The Prostate / Prostate. 2001 May 15;47(3):205-11. doi: 10.1002/pros.1064.

2001
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A;

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. in The Journal of urology / J Urol. 2000 Oct;164(4):1248-53.

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;

Circulating neuroendocrine markers in patients with prostate carcinoma. in Cancer / Cancer. 2000 Jun 1;88(11):2590-7. doi: 10.1002/1097-0142(20000601)88:11<2590::aid-cncr23>3.0.co;2-d.

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Bellina M; Mari M; Torta M; Tarabuzzi R; Bollito E; Fontana D; Angeli A;

Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer. in The Journal of urology / J Urol. 1999 Jan;161(1):176-81.

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Fasolis G; Mosca A; Tarabuzzi R; Torta M; Mari M; Fontana D; Angeli A;

Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases. in Clinical chemistry / Clin Chem. 1999 Aug;45(8 Pt 1):1240-7.

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;

Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. in The Prostate / Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2

1997
AOU San Luigi di Orbassano

Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A;

Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.

1995
AOU San Luigi di Orbassano

Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;

Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone metastases. in The International journal of biological markers / Int J Biol Markers. 1994 Oct-Dec;9(4):243-6. doi: 10.1177/172460089400900407.

1994
AOU San Luigi di Orbassano

Piovesan A; Berruti A; Osella G; Raucci CA; Torta M; Dogliotti L; Angeli A;

Effects of exogenous melatonin on human pituitary and adrenal secretions. Hormonal responses to specific stimuli after acute administration of different doses at two opposite circadian stages in men. in Chronobiologia / Chronobiologia. 1988 Oct-Dec;15(4):279-87.

1988
AOU San Luigi di Orbassano

Paccotti P; Terzolo M; Piovesan A; Torta M; Vignani A; Angeli A;

Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol. in Journal of endocrinological investigation / J Endocrinol Invest. 1988 Nov;11(10):717-21. doi: 10.1007/BF03350926.

1988
AOU San Luigi di Orbassano

Terzolo M; Panarelli M; Piovesan A; Torta M; Paccotti P; Angeli A;